mpilo
臨床アシスタント · 3.3K 月間訪問数
mpiloは、医療専門家向けのAI搭載医療アシスタントです。患者との診察内容をリアルタイムで聞き取り、SOAPノートなど、正確でHIPAAに準拠した臨床記録を自動で作成します。文書作成を自動化することで、mpiloは管理業務の負担を軽減し、燃え尽き症候群を最小限に抑え、臨床医がより患者ケアに集中できるようにします。安全で様々な専門分野に適応し、独自の文書スタイルを学習して、シームレスなワークフロー統合を実現します。
VS
NoteMD
臨床支援 · 1.2K 月間訪問数
NoteMDは、臨床医が文書作成時間を大幅に削減するために設計されたAI搭載の医療書記です。患者の診察を文字起こしし、構造化されたSOAPノートを自動生成することで、医療専門家が毎日最大2時間を節約できるよう支援します。このプラットフォームは完全にHIPAAに準拠し、安全で、どのデバイスからでもアクセスでき、医師が事務作業よりも患者ケアに集中できるようサポートします。
製品概要
mpilo 製品概要
mpiloは、医療専門家向けのAI搭載医療アシスタントです。患者との診察内容をリアルタイムで聞き取り、SOAPノートなど、正確でHIPAAに準拠した臨床記録を自動で作成します。文書作成を自動化することで、mpiloは管理業務の負担を軽減し、燃え尽き症候群を最小限に抑え、臨床医がより患者ケアに集中できるようにします。安全で様々な専門分野に適応し、独自の文書スタイルを学習して、シームレスなワークフロー統合を実現します。
Preview
NoteMD 製品概要
NoteMDは、臨床医が文書作成時間を大幅に削減するために設計されたAI搭載の医療書記です。患者の診察を文字起こしし、構造化されたSOAPノートを自動生成することで、医療専門家が毎日最大2時間を節約できるよう支援します。このプラットフォームは完全にHIPAAに準拠し、安全で、どのデバイスからでもアクセスでき、医師が事務作業よりも患者ケアに集中できるようサポートします。
Preview
Detailed feature comparison
mpilo vs NoteMD monthly traffic
Compare mpilo and NoteMD by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the mpilo vs NoteMD monthly traffic comparison, mpilo currently shows 3.3K visits and NoteMD shows 1.2K; mpilo has about 2.7 times the visible traffic of NoteMD, an absolute difference of about 2.1K visits. This reflects visible reach, not feature quality or paid users.
Only NoteMD has complete third-party traffic details; mpilo uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
mpilo monthly traffic:
Latest traffic
月間訪問数
3.3K
NoteMD monthly traffic:
Latest traffic
月間訪問数
1.2K
平均滞在時間
0:00
訪問あたりページ数
1.1
直帰率
38.27%
Data updated 2026-06-15
Monthly traffic trend
- 2025/7: 263 月間訪問数
- 2025/8: 949 月間訪問数
- 2025/9: 1.2K 月間訪問数
- 2026/3: 0 月間訪問数
- 2026/4: 0 月間訪問数
- 2026/5: 1.2K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 100% | 1.2K |
検索キーワード
notemd
Traffic-based selection guidance: The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Usage comparison
Compare the core capabilities of mpilo and NoteMD
mpilo Core features
医療文書
文字起こし
臨床アシスタント
NoteMD Core features
医療文書
文字起こし
臨床支援
Use cases
mpilo Use cases
電子健康記録
ヘルスケア
HIPAA
医療クラーク
医療転写
SOAPノート
診療記録
臨床医のバーンアウト
医師アシスタント
患者記録
NoteMD Use cases
電子健康記録
ヘルスケア
HIPAA
医療クラーク
医療転写
SOAPノート
AI書記
臨床文書
医師の燃え尽き症候群
文字起こし
mpilo vs NoteMD：In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth mpilo vs NoteMD comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. mpilo is primarily listed under “臨床アシスタント”, while NoteMD is primarily listed under “臨床支援”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (mpilo: 臨床アシスタント; NoteMD: 臨床支援); Monthly visits (mpilo: 3.3K; NoteMD: 1.2K); Favorites (mpilo: 115; NoteMD: 116); Website (mpilo: mpilo.ai; NoteMD: www.notemd.ai); Added (mpilo: 2025-08-03; NoteMD: 2025-08-12). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the mpilo vs NoteMD monthly traffic comparison, mpilo currently shows 3.3K visits and NoteMD shows 1.2K; mpilo has about 2.7 times the visible traffic of NoteMD, an absolute difference of about 2.1K visits. This reflects visible reach, not feature quality or paid users.
Only NoteMD has complete third-party traffic details; mpilo uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
mpilo and NoteMD currently overlap in shared categories: 医療文書、文字起こし; shared tags: 電子健康記録、ヘルスケア、HIPAA、医療クラーク、医療転写、SOAPノート. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
mpilo's unique categories/tags are 臨床アシスタント、診療記録、臨床医のバーンアウト、医師アシスタント、患者記録; NoteMD's are 臨床支援、AI書記、臨床文書、医師の燃え尽き症候群、文字起こし. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
mpilo has no verified rating, 0 comments, 115 favorites, and 122 likes；NoteMD has no verified rating, 0 comments, 116 favorites, and 125 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate mpilo first
Put mpilo on the priority trial list when the task aligns with “臨床アシスタント” and especially 臨床アシスタント、診療記録、臨床医のバーンアウト、医師アシスタント、患者記録. This follows recorded positioning and does not imply unlisted capabilities are absent.
mpilo also currently records: pricing is freemium, product type is website, 3.3K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate NoteMD first
Put NoteMD on the priority trial list when the task aligns with “臨床支援” and especially 臨床支援、AI書記、臨床文書、医師の燃え尽き症候群、文字起こし. This follows recorded positioning and does not imply unlisted capabilities are absent.
NoteMD also currently records: pricing is freemium, product type is website, 1.2K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in mpilo and NoteMD, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
比較 FAQ
How should I choose between mpilo and NoteMD?
Compare positioning, pricing, taxonomy, and traffic maturity, then verify the latest details on each official website.
Where does this comparison data come from?
The factual baseline is derived from product, taxonomy, traffic, and community data. Reviewed editorial conclusions show their source and verification date.
What do unknown fields mean?
Unknown means there is not enough reliable evidence; the page does not fill gaps with assumptions.